SCHEMBL20739827

SCHEMBL20739827

CCCCCC/C=C\CCCCCCCC(=O)Oc1ccccc1OC

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLM Q9NP87 2/20 0.62
▸ POLK Q9UBT6 2/20 0.62
▸ POLL Q9UGP5 2/20 0.62
▸ POLH Q9Y253 2/20 0.62
▸ TOP2A P11388 1/20 0.55
▸ EPHX2 P34913 1/20 0.52
▸ HTR2A P28223 1/20 0.52
▸ KDM4E B2RXH2 3/20 0.51
▸ SOAT1 P35610 3/20 0.51
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ RECQL P46063 1/20 0.51
▸ SOAT2 O75908 1/20 0.51
▸ ELANE P08246 1/20 0.51
▸ PPARG P37231 1/20 0.51
▸ FAAH O00519 1/20 0.50
▸ TP53 P04637 1/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP3A4 P08684 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26090058 1.00 POLM (0.62) POLMPOLKPOLLPOLHTOP2A
SCHEMBL30666136 0.94 POLM (0.67) POLMPOLKPOLLPOLHEPHX2
SCHEMBL4083842 0.92 MEN1 (0.59) POLMPOLKPOLLPOLHTOP2A
SCHEMBL4089868 0.92 MEN1 (0.59) POLMPOLKPOLLPOLHTOP2A
SCHEMBL22975372 0.92 MEN1 (0.59) POLMPOLKPOLLPOLHTOP2A
SCHEMBL4083649 0.92 MEN1 (0.59) POLMPOLKPOLLPOLHTOP2A
SCHEMBL9186714 0.92 MEN1 (0.59) POLMPOLKPOLLPOLHTOP2A
SCHEMBL4090350 0.90 MEN1 (0.60) POLMPOLKPOLLPOLHTOP2A
SCHEMBL9670150 0.89 MEN1 (0.50) POLMPOLKPOLLPOLHTOP2A
SCHEMBL26090061 0.87 POLM (0.51) POLMPOLKPOLLPOLHEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019030643-A1 COMPOSITIONS OF EUGENOL DERIVATIVES FOR TREATMENT OF VISCERAL LEISHMANIASIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2019-02-14 — — WO disclosed
Send feedback